Market Live Email
21 Dec
AstraZeneca announces two drug approvals in the EU
AstraZeneca announced two EU approvals on Wednesday, with Imfinzi approved for biliary tract cancer, and Lynparza for prostate cancer.
21 Dec
Ferrexpo bringing pelletiser back online in Ukraine, Anglo American's De Beers sales fall
London open.